Latest Filings

Issuer Activity

Insider Overview :: Sirona Biochem Corp. (V:SBM) [?]
Business Focus: Biotechnology & Medical Research
Recent Price for SBM
CAD 0.100 +0.01 (+5.00%)
TSXV Delayed 15 minutes
May 22 1559 EDT
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.150 0.0 N/A 9.41
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.030 0.0% 111,583  
Log in or sign up for a free account to add this stock to your watch list.
Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for SBM within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 21st, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
May 7/13 May 7/13 Verrico, Christopher Direct Ownership Warrants 53 - Grant of warrants 1,500,000  
May 7/13 May 7/13 Verrico, Christopher Direct Ownership Common Shares 16 - Acquisition under a prospectus exemption 1,500,000 $0.100
Apr 29/13 Apr 29/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 40,000 $0.085
Apr 21/13 Apr 19/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 9,000 $0.085
Apr 18/13 Apr 18/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 71,000 $0.085
Apr 4/13 Apr 3/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -84,961 $0.090
Apr 1/13 Mar 27/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -100,000 $0.095
Mar 27/13 Mar 26/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -27,000 $0.105
Mar 27/13 Mar 26/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -250,000 $0.100
Mar 27/13 Mar 25/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -3,000 $0.105
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for SBM within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 21st, 2013
Filing
Date 		Transaction
Date 		Insider Name Ownership
Type 		Securities Nature of transaction # or value acquired or disposed of Price
May 7/13 May 7/13 Verrico, Christopher Direct Ownership Warrants 53 - Grant of warrants 1,500,000  
May 7/13 Apr 17/07 Verrico, Christopher Direct Ownership Warrants 00 - Opening Balance-Initial SEDI Report    
May 7/13 May 7/13 Verrico, Christopher Direct Ownership Common Shares 16 - Acquisition under a prospectus exemption 1,500,000 $0.100
Apr 29/13 Apr 29/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 40,000 $0.085
Apr 21/13 Apr 19/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 9,000 $0.085
Apr 18/13 Apr 18/13 Verrico, Howard Jarman Direct Ownership Common Shares 10 - Acquisition in the public market 71,000 $0.085
Apr 4/13 Apr 3/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -84,961 $0.090
Apr 1/13 Mar 27/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -100,000 $0.095
Mar 29/13 Dec 19/12 Rogers, Michael Direct Ownership Common Shares 10 - Acquisition in the public market 36,000 $0.080
Mar 27/13 Mar 26/13 Verrico, Christopher Direct Ownership Common Shares 10 - Disposition in the public market -27,000 $0.105
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for SBM on May 21, 2013 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Biotechnology & Medical Research
Key People
Howard Verrico
Chairman of the Board, Interim President, Secretary 		Neil Belenkie
Chief Executive Officer 		Christopher D. Hopton
Chief Financial Officer, Director
Sean Cunliffe
Chief Business Officer 		   
Company Contact
Address: 955-789 West Pender St.
VANCOUVER BC V6C 1H2
Tel: 1-604-6847994
Website: www.sironabiochem.com
IR: See website
Business Overview
Sirona Biochem Corp. is a Canada-based, development-stage company. The Company is engaged in the discovery and development of drug compounds with a focus on treatments for Type II Diabetes and Obesity. It is specializes in the development of carbohydrate-based molecules. It is also focused on advancing three programs: therapeutics, cosmetic agents and biological ingredients. The Company's wholly owned subsidiary, TFCHEM S.A.R.L (TFC), has developed a platform technology based upon fluorinated sugar mimics for the treatment of diabetes and obesity. TFC focuses on carrying out a two year research program to develop a chemical process to achieve the synthesis of a new class of Sodium Glucose Co-transporter Inhibitors for the treatment of Type II Diabetes and Obesity. On March 31, 2011, the Company completed the acquisition of TFCHEM S.A.R.L (TFC).
Competitors with Recent Insider Filings
QLT (T:QLT)
EnWave (V:ENW)
iCo Therapeutics (V:ICO)
 
Sirona Biochem Corp. Insider Report Only $20.00